Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy

ACS Nano

Volumn 9, Issue 3, 2015, Pages 2405-2419

  Zhang, Zhengping ^a   Wang, Chunming ^b   Zha, Yinhe ^a   Hu, Wei ^a   Gao, Zhongfei ^a   Zang, Yuhui ^a   Chen, Jiangning ^a   Zhang, Junfeng ^a   Dong, Lei ^a  

^a NANJING UNIVERSITY   (China)

^b University of Macau   (Macao)

Author keywords

drug nanocarriers; hepatic fibrosis; protein corona; retinol; targeted delivery

Indexed keywords

CARDIOVASCULAR SYSTEM; CHLORINE COMPOUNDS; COLLAGEN; CONTROLLED DRUG DELIVERY; LIGANDS; NANOPARTICLES; NUCLEIC ACIDS; OLIGONUCLEOTIDES;

HEPATIC FIBROSIS; NANO-CARRIERS; PROTEIN CORONAS; RETINOL; TARGETED DELIVERY;

TARGETED DRUG DELIVERY;

ALBUMINOID; ANTISENSE OLIGONUCLEOTIDE; DRUG CARRIER; NANOPARTICLE; POLYETHYLENEIMINE; PROTEIN CORONA; RETINOL; RETINOL BINDING PROTEIN;

ANIMAL; CELL LINE; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; HUMAN; LIVER CIRRHOSIS; MALE; METABOLISM; MOUSE; PATHOLOGY; STELLATE CELL; TISSUE DISTRIBUTION;

ALBUMINS; ANIMALS; CELL LINE; DRUG CARRIERS; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MALE; MICE; NANOPARTICLES; OLIGONUCLEOTIDES, ANTISENSE; POLYETHYLENEIMINE; PROTEIN CORONA; RETINOL-BINDING PROTEINS; TISSUE DISTRIBUTION; TRANSFECTION; VITAMIN A;

EID: 84925687510     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn505166x     Document Type: Article

References (42)

1. Jain, K. K. Nanoparticles as Targeting Ligands Trends Biotechnol. 2006, 24, 143-145
2. Boyer, C.; Teo, J.; Phillips, P.; Erlich, R. B.; Sagnella, S.; Sharbeen, G.; Dwarte, T.; Duong, H. T.; Goldstein, D.; Davis, T. et al. Effective Delivery of SiRNA into Cancer Cells and Tumors Using Well-Defined Biodegradable Cationic Star Polymers Mol. Pharmaceutics 2013, 10, 2435-2444
3. Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking Down Barriers: Advances in siRNA Delivery Nat. Rev. Drug Discovery 2009, 8, 129-138
4. Monopoli, M. P.; Aberg, C.; Salvati, A.; Dawson, K. A. Biomolecular Coronas Provide the Biological Identity of Nanosized Materials Nat. Nanotechnol. 2012, 7, 779-786
5. Mirshafiee, V.; Mahmoudi, M.; Lou, K.; Cheng, J.; Kraft, M. L. Protein Corona Significantly Reduces Active Targeting Yield Chem. Commun. 2013, 49, 2557-2559
6. Salvati, A.; Pitek, A. S.; Monopoli, M. P.; Prapainop, K.; Bombelli, F. B.; Hristov, D. R.; Kelly, P. M.; Åberg, C.; Mahon, E.; Dawson, K. A. Transferrin-Functionalized Nanoparticles Lose Their Targeting Capabilities When a Biomolecule Corona Adsorbs on the Surface Nat. Nanotechnol. 2013, 8, 137-143
7. Lesniak, A.; Salvati, A.; Santos-Martinez, M. J.; Radomski, M. W.; Dawson, K. A.; Åberg, C. Nanoparticle Adhesion to the Cell Membrane and Its Effect on Nanoparticle Uptake Efficiency J. Am. Chem. Soc. 2013, 135, 1438-1444
8. Prapainop, K.; Witter, D. P.; Wentworth, P., Jr. A Chemical Approach for Cell-Specific Targeting of Nanomaterials: Small-Molecule-Initiated Misfolding of Nanoparticle Corona Proteins J. Am. Chem. Soc. 2012, 134, 4100-4103
9. Pardridge, W. M. Transport of Protein-Bound Hormones into Tissues in Vivo Endocr. Rev. 1981, 2, 103-123
10. Fortuna, V. A.; Martucci, R. B.; Trugo, L. C.; Borojevic, R. Hepatic Stellate Cells Uptake of Retinol Associated with Retinol-Binding Protein or With Bovine Serum Albumin J. Cell Biochem. 2003, 90, 792-805
11. Mahley, R. W.; Rall, S. C., Jr. Apolipoprotein E: Far More Than a Lipid Transport Protein Annu. Rev. Genomics Hum. Genet. 2000, 1, 507-537
12. Quadro, L.; Blaner, W. S.; Salchow, D. J.; Vogel, S.; Piantedosi, R.; Gouras, P.; Freeman, S.; Cosma, M. P.; Colantuoni, V.; Gottesman, M. E. Impaired Retinal Function and Vitamin A Availability in Mice Lacking Retinol-Binding Protein EMBO J. 1999, 18, 4633-4644
13. Meir, K. S.; Leitersdorf, E. Atherosclerosis in the Apolipoprotein-E-Deficient Mouse: A Decade of Progress Arterioscler., Thromb., Vasc. Biol. 2004, 24, 1006-1014
14. Noy, N.; Xu, Z. J. Interactions of Retinol with Binding Proteins: Implications for the Mechanism of Uptake by Cells Biochemistry 1990, 29, 3878-3883
15. Vogel, S.; Piantedosi, R.; Frank, J.; Lalazar, A.; Rockey, D. C.; Friedman, S. L.; Blaner, W. S. An Immortalized Rat Liver Stellate Cell Line (HSC-T6): a New Cell Model for the Study of Retinoid Metabolism in Vitro J. Lipid Res. 2000, 41, 882-893
16. Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. Nanoparticle Interaction with Plasma Proteins As It Relates to Particle Biodistribution, Biocompatibility and Therapeutic Efficacy Adv. Drug Deliv Rev. 2009, 61, 428-437
17. Mahon, E.; Salvati, A.; Bombelli, F.; Lynch, I.; Dawson, K. A. Designing the Nanoparticle-Biomolecule Interface for "Targeting and Therapeutic Delivery" J. Controlled Release 2012, 161, 164-174
18. Curry, S.; Mandelkow, H.; Brick, P.; Franks, N. Crystal Structure of Human Serum Albumin Complexed with Fatty Acid Reveals an Asymmetric Distribution of Binding Sites Nat. Struct. Biol. 1998, 5, 827-835
19. Nicholson, J. P.; Wolmarans, M. R.; Park, G. R. The Role of Albumin in Critical Illness Br. J. Anaesth. 2000, 85, 599-610
20. Kratz, F. Albumin as a Drug Carrier: Design of Prodrugs, Drug Conjugates and Nanoparticles J. Controlled Release 2008, 132, 171-183
21. Sivaprasadarao, A.; Findlay, J. B. The Mechanism of Uptake of Retinol by Plasma-Membrane Vesicles Biochem. J. 1988, 255, 571-579
22. Chonn, A.; Cullis, P. R.; Devine, D. V. The Role of Surface Charge in the Activation of the Classical and Alternative Pathways of Complement by Liposomes J. Immunol. 1991, 146, 4234-4241
23. Blaner, W. S.; OByrne, S. M.; Wongsiriroj, N.; Kluwe, J.; DAmbrosio, D. M.; Jiang, H.; Schwabe, R. F.; Hillman, E. M.; Piantedosi, R.; Libien, J. Hepatic Stellate Cell Lipid Droplets: a Specialized Lipid Droplet for Retinoid Storage Biochim. Biophys. Acta 2009, 1791, 467-473
24. Blomhoff, R.; Berg, T.; Norum, K. R. Transfer of Retinol from Parenchymal to Stellate Cells in Liver Is Mediated by Retinol-Binding Protein Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 3455-3458
25. Senoo, H.; Smeland, S.; Malaba, L.; Bjerknes, T.; Stang, E.; Roos, N.; Berg, T.; Norum, K. R.; Blomhoff, R. Transfer of Retinol-Binding Protein from HepG2 Human Hepatoma Cells to Cocultured Rat Stellate Cells Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 3616-3620
26. Sato, Y.; Murase, K.; Kato, J.; Kobune, M.; Sato, T.; Kawano, Y.; Takimoto, R.; Takada, K.; Miyanishi, K.; Matsunaga, T. et al. Resolution of Liver Cirrhosis Using Vitamin A-Coupled Liposomes To Deliver siRNA Against a Collagen-Specific Chaperone Nat. Biotechnol. 2008, 26, 431-442
27. Liu, W.; Rose, J.; Plantevin, S.; Auffan, M.; Bottero, J. Y.; Vidaud, C. Protein Corona Formation for Nanomaterials and Proteins of a Similar Size: Hard or Soft Corona? Nanoscale 2013, 5, 1658-1668
28. Lundqvist, M.; Stigler, J.; Cedervall, T.; Berggård, T.; Flanagan, M. B.; Lynch, I.; Elia, G.; Dawson, K. The Evolution of the Protein Corona around Nanoparticles: A Test Study ACS Nano 2011, 5, 7503-7509
29. Walkey, C. D.; Olsen, J. B.; Guo, H.; Emili, A.; Chan, W. C. Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake J. Am. Chem. Soc. 2012, 134, 2139-2147
30. Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G. J.; Puntes, V. Time Evolution of the Nanoparticle Protein Corona ACS Nano 2010, 4, 3623-3632
31. Milani, S.; Bombelli, F. B.; Pitek, A. S.; Dawson, K. A.; Rädler, J. Reversible versus Irreversible Binding of Transferrin to Polystyrene Nanoparticles: Soft and Hard Corona ACS Nano 2012, 6, 2532-2541
32. Friedman, S. L. Mechanisms of Hepatic Fibrogenesis Gastroenterology. 2008, 134, 1655-1669
33. Friedman, S. L. Seminars in Medicine of the Beth Israel Hospital, Boston. The Cellular Basis of Hepatic Fibrosis. Mechanisms and Treatment Strategies N. Engl. J. Med. 1993, 328, 1828-1835
34. Henderson, N. C.; Iredale, J. P. Liver Fibrosis: Cellular Mechanisms of Progression and Resolution Clin. Sci. 2007, 112, 265-280
35. Popov, Y.; Schuppan, D. Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies Hepatology 2009, 50, 1294-1306
36. Yan, Z.; Chen, M.; Perucho, M.; Friedman, E. Oncogenic Ki-ras But Not Oncogenic Ha-Ras Blocks Integrin Beta1-Chain Maturation in Colon Epithelial Cells J. Biol. Chem. 1997, 272, 30928-30936
37. Dong, L.; Xia, S.; Chen, H.; Chen, J.; Zhang, J. Spleen-Specific Suppression of TNF-Alpha by Cationic Hydrogel-Delivered Antisense Nucleotides for the Prevention of Arthritis in Animal Models Biomaterials 2009, 30, 4416-4426
38. Tenzer, S.; Docter, D.; Kuharev, J.; Musyanovych, A.; Fetz, V.; Hecht, R.; Schlenk, F.; Fischer, D.; Kiouptsi, K.; Reinhardt, C. et al. Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology Nat. Nanotechnol. 2013, 8, 772-781
39. Bataller, R.; Sancho-Bru, P.; Ginès, P.; Lora, J. M.; Al-Garawi, A.; Solé, M.; Colmenero, J.; Nicolás, J. M.; Jiménez, W.; Weich, N. et al. Activated Human Hepatic Stellate Cells Express the Renin-Angiotensin System and Synthesize Angiotensin II Gastroenterology 2003, 125, 117-125
40. Lee, J. I.; Lee, K. S.; Paik, Y. H.; Nyun Park, Y.; Han, K. H.; Chon, C. Y.; Moon, Y. M. Apoptosis of Hepatic Stellate Cells in Carbon Tetrachloride Induced Acute Liver Injury of the Rat: Analysis of Isolated Hepatic Stellate Cells J. Hepatol. 2003, 39, 960-966
41. Huang, Z.; Zhang, Z.; Jiang, Y.; Zhang, D.; Chen, J.; Dong, L.; Zhang, J. Targeted Delivery of Oligonucleotides into Tumor-Associated Macrophages for Cancer Immunotherapy J. Controlled Release 2012, 158, 286-292
42. Mencin, A.; Seki, E.; Osawa, Y.; Kodama, Y.; De Minicis, S.; Knowles, M.; Brenner, D. A.; Alpha-1 Antitrypsin, Z. Protein (PiZ) Increases Hepatic Fibrosis in a Murine Model of Cholestasis Hepatology 2007, 46, 1443-1452